Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,569 | 273 | 98.8% |
| Entertainment | $49.15 | 1 | 0.9% |
| Education | $17.54 | 2 | 0.3% |
| Unspecified | $0 | 1 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,208 | 70 | $0 (2022) |
| Janssen Scientific Affairs, LLC | $787.57 | 7 | $0 (2022) |
| PFIZER INC. | $495.95 | 28 | $0 (2022) |
| Janssen Biotech, Inc. | $427.50 | 35 | $0 (2022) |
| Ethicon US, LLC | $258.92 | 5 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $254.83 | 15 | $0 (2022) |
| Braintree Laboratories, Inc. | $219.42 | 6 | $0 (2022) |
| Ferring Pharmaceuticals Inc. | $174.94 | 12 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $160.85 | 10 | $0 (2022) |
| Ardelyx, Inc. | $157.40 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $1,555 | 58 | ABBVIE INC. ($269.55) |
| 2021 | $724.22 | 16 | AbbVie Inc. ($165.32) |
| 2020 | $453.52 | 23 | Janssen Scientific Affairs, LLC ($110.42) |
| 2019 | $1,094 | 63 | AbbVie, Inc. ($236.40) |
| 2018 | $1,242 | 77 | AbbVie, Inc. ($343.95) |
| 2017 | $567.65 | 40 | AbbVie, Inc. ($192.47) |
All Payment Transactions
277 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: Gastroenterology | ||||||
| 11/17/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.34 | General |
| Category: IMMUNOLOGY | ||||||
| 11/16/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: Gastroenterology | ||||||
| 11/09/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Gastroenterology | ||||||
| 11/01/2022 | Organon LLC | RENFLEXIS (Drug) | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: INFLIXIMAB | ||||||
| 10/26/2022 | PFIZER INC. | XELJANZ (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/13/2022 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 10/06/2022 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $27.33 | General |
| Category: THERAPY FOR CSID | ||||||
| 10/04/2022 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/29/2022 | Braintree Laboratories, Inc. | SUTAB (Drug) | Food and Beverage | In-kind items and services | $45.30 | General |
| Category: GI COLON PREP | ||||||
| 09/27/2022 | Organon LLC | RENFLEXIS (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: INFLIXIMAB | ||||||
| 09/15/2022 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/14/2022 | Janssen Scientific Affairs, LLC | STELARA (Biological), REMICADE | Food and Beverage | In-kind items and services | $107.39 | General |
| Category: Immunology | ||||||
| 09/12/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Immunology | ||||||
| 09/08/2022 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/07/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: Gastroenterology | ||||||
| 09/01/2022 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $34.47 | General |
| Category: THERAPY FOR CSID | ||||||
| 08/30/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $16.68 | General |
| Category: Neuroscience | ||||||
| 08/24/2022 | Janssen Biotech, Inc. | STELARA (Biological), REMICADE | Food and Beverage | In-kind items and services | $28.73 | General |
| Category: Immunology | ||||||
| 08/16/2022 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $29.73 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/11/2022 | RedHill Biopharma Inc. | Talicia (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: Antibiotic | ||||||
| 08/10/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $31.20 | General |
| Category: Gastroenterology | ||||||
| 08/09/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.55 | General |
| Category: IMMUNOLOGY | ||||||
| 08/02/2022 | Braintree Laboratories, Inc. | SUTAB (Drug) | Food and Beverage | In-kind items and services | $50.18 | General |
| Category: GI COLON PREP | ||||||
| 07/28/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: Iron Deficiency Anemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 9 | 529 | 551 | $339,881 | $59,351 |
| 2021 | 10 | 881 | 924 | $574,227 | $102,310 |
| 2020 | 13 | 869 | 921 | $538,951 | $96,585 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 116 | 116 | $98,252 | $14,243 | 14.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 57 | 57 | $60,819 | $11,281 | 18.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 46 | 46 | $35,791 | $8,191 | 22.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 97 | 99 | $65,628 | $6,694 | 10.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 61 | 69 | $14,973 | $6,071 | 40.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 83 | 86 | $12,728 | $4,985 | 39.2% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 37 | 46 | $29,854 | $4,164 | 13.9% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 20 | 20 | $15,620 | $2,733 | 17.5% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 12 | 12 | $6,216 | $990.03 | 15.9% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 121 | 121 | $129,107 | $24,222 | 18.8% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 220 | 220 | $186,340 | $23,974 | 12.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2021 | 72 | 72 | $56,016 | $13,071 | 23.3% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 145 | 155 | $90,830 | $10,217 | 11.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 69 | 81 | $17,577 | $7,638 | 43.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 108 | 114 | $16,872 | $7,200 | 42.7% |
| 43249 | Balloon dilation of esophagus, stomach and upper small bowel using a flexible endoscope | Facility | 2021 | 57 | 71 | $46,079 | $7,113 | 15.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 40 | 40 | $13,280 | $4,978 | 37.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 26 | 26 | $5,694 | $2,088 | 36.7% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 23 | 24 | $12,432 | $1,808 | 14.5% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 214 | 214 | $181,258 | $25,869 | 14.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope | Facility | 2020 | 91 | 91 | $97,097 | $18,938 | 19.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2020 | 53 | 53 | $41,234 | $9,988 | 24.2% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 144 | 154 | $90,244 | $9,739 | 10.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 138 | 154 | $22,792 | $8,421 | 36.9% |
| 43249 | Balloon dilation of esophagus using an endoscope | Facility | 2020 | 58 | 72 | $46,728 | $7,383 | 15.8% |
About Dr. Stephen Lacey, M.D
Dr. Stephen Lacey, M.D is a Gastroenterology healthcare provider based in Southlake, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1316923261.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Lacey, M.D has received a total of $5,636 in payments from pharmaceutical and medical device companies, with $1,555 received in 2022. These payments were reported across 277 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($5,569).
As a Medicare-enrolled provider, Lacey has provided services to 2,279 Medicare beneficiaries, totaling 2,396 services with total Medicare billing of $258,245. Data is available for 3 years (2020–2022), covering 32 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Southlake, TX
- Active Since 12/21/2005
- Last Updated 05/23/2013
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1316923261
Products in Payments
- STELARA (Biological) $1,215
- Humira (Biological) $565.05
- XELJANZ (Drug) $256.21
- SUTAB (Drug) $219.42
- INFLECTRA (Biological) $184.24
- ZEPOSIA (Drug) $182.82
- CLENPIQ (Drug) $162.64
- IBSRELA (Drug) $157.40
- RINVOQ (Biological) $155.67
- XIFAXAN (Drug) $154.48
- LINX Reflux Management System (Device) $144.06
- OCALIVA (Drug) $137.85
- Creon (Drug) $118.96
- INJECTAFER (Drug) $101.39
- DIFICID (Drug) $100.46
- TRULANCE (Drug) $98.29
- Alinia Tablets 500mg 30 count bottle (Drug) $93.74
- ENTYVIO (Biological) $87.21
- Linzess (Drug) $85.53
- Smart Pill (Device) $72.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Southlake
Dr. Timothy Ritter, M.d, M.D
Gastroenterology — Payments: $1.1M
Dr. David Levitan, M.d, M.D
Gastroenterology — Payments: $26,370
Dr. James Weber, M.d, M.D
Gastroenterology — Payments: $17,582
Dr. David Spady, M.d, M.D
Gastroenterology — Payments: $12,464
Dr. Jeffrey Smith, M.d, M.D
Gastroenterology — Payments: $5,235
Dr. Azaan Ramani, Do, DO
Gastroenterology — Payments: $4,793